Get startedLog in
    Picture of Heron Therapeutics logo

    HRTX — Heron Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Heron Therapeutics Announces Acceptance Of Prior Approval Supplement Application For ZYNRELEF Vial Access Needle

    Picture of Heron Therapeutics logoHeron Therapeutics
    02/07/2024 13:06
    July 2 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES ACCEPTANCE OF THE PRIOR
APPROVAL
SUPPLEMENT APPLICATION FOR ZYNRELEF® VIAL ACCESS NEEDLE ("VAN")
    * HERON THERAPEUTICS INC - U.S. FOOD AND DRUG ADMINISTRATION
("FDA") ASSIGNED A PRESCRIPTION DRUG USER FEE ACT ("PDUFA") GOAL
DATE OF SEPTEMBER 23, 2024

Source text for Eikon:  ID:nPn7YZsCja 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Heron Therapeutics

    See all news